Citation Impact
Citing Papers
Mycotoxins, drugs and other extrolites produced by species in Penicillium subgenus Penicillium
2004
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate
1992
Heparin-Protein Interactions
2002 Standout
Fungal Phenalenones Inhibit HIV-1 Integrase
2005 StandoutNobel
Increasing Incidence of Adenovirus Disease in Bone Marrow Transplant Recipients
1994
The chemistry and biology of mucin-type O-linked glycosylation
2005 StandoutNobel
Quinoxaline, its derivatives and applications: A State of the Art review
2014 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Glycosylation inhibitors in biology and medicine
1995
Natural products: An evolving role in future drug discovery
2011 Standout
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Prevalence of sexual abuse among women seeking gynecologic care in Germany
2003
Valganciclovir in Adult Solid Organ Transplant Recipients
2009
Transfusion Medicine — Blood Transfusion
1999 Standout
Deoxynojirimycin: synthesis and biological activity
1994
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Antiviral resistance of stem cells
2018 StandoutNobel
Improving enzymes by using them in organic solvents
2001 StandoutNature
Biological roles of glycans
2016 Standout
Humic acids: Structural properties and multiple functionalities for novel technological developments
2015 Standout
Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors
1996
Simple indolizidine and quinolizidine alkaloids
2001
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Targeting glycosylation as a therapeutic approach
2002
Simple Indolizidine and Quinolizidine Alkaloids
2015
Design of dimerization inhibitors of HIV-1 aspartic proteinase: A computer-based combinatorial approach
2000 StandoutNobel
Biological Correlates of Abuse in Women with Premenstrual Dysphoric Disorder and Healthy Controls
2003
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
New developments in anti-HIV chemotherapy
2001
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication
1999
Oncostatin M, a Cytokine Released by Activated Mononuclear Cells, Induces Epithelial Cell-Myofibroblast Transdifferentiation via Jak/Stat Pathway Activation
2004
Anti-HIV-1 Activity of Chemically Modified Heparins: Correlation between Binding to the V3 Loop of gp120 and Inhibition of Cellular HIV-1 Infection in vitro
1994
Optimization of PCR-based diagnostics for human cytomegalovirus
1995
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo
2000
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
1999 Standout
Prenylated indole derivatives from fungi: structure diversity, biological activities, biosynthesis and chemoenzymatic synthesis
2009 Standout
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Phosphine-triggered synthesis of functionalized cyclic compounds
2008 Standout
Leukocyte reduction of blood components: Public policy and new technology
2000
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
2007 Standout
Prevalence of obstructive sleep apnea in the general population: A systematic review
2016 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
The risk of transfusion‐acquired CMV infection in seronegative solid‐organ transplant recipients receiving non‐WBC‐reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center
2002
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.
2007 Standout
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
2013
Indolizidine and quinolizidine alkaloids
2004 Standout
Organic Azides: An Exploding Diversity of a Unique Class of Compounds
2005 Standout
Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells
2002 Standout
Lifetime prevalence of sexual abuse in a Swedish pregnant population
2003
Cidofovir for the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplant Patients
2006
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
A Global Perspective on Child Sexual Abuse: Meta-Analysis of Prevalence Around the World
2011 Standout
Tetrazoles of manno- and rhamno-pyranoses: Contrasting inhibition of mannosidases by [4.3.0] but of rhamnosidase by [3.3.0] bicyclic tetrazoles
1999
Application of biocatalysis and biotransformations to the synthesis of pharmaceuticals
1997
Roles of N-Linked Glycans in the Endoplasmic Reticulum
2004 Standout
Stereoselective Synthesis ofanti-α-(Difluoromethyl)-β-amino Alcohols by Boronic Acid Based Three-Component Condensation. Stereoselective Preparation of (2S,3R)-Difluorothreonine
2002 Nobel
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
2009
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
2002
Antiviral therapy for human immunodeficiency virus infections
1995
Antiviral drug discovery: broad-spectrum drugs from nature
2014
Poly(Hydroxy)Carboxylates as Selective Inhibitors of Cytomegalovirus and Herpes Simplex Virus Replication
1992
The ProTide Prodrug Technology: From the Concept to the Clinic
2017
Recent applications of the Suzuki–Miyaura cross-coupling reaction in organic synthesis
2002 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells
1998
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
2012 Standout
Biologic effects of leukocytes present in transfused cellular blood products
1994
The HIV gp120-CD4 interaction: A target for pharmacological or immunological intervention?
1993
Domestic Violence Against Women: Systematic Review of Prevalence Studies
2009
Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication
1996
Plant Products as Antimicrobial Agents
1999 Standout
Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo
2005
Palladium-Catalyzed Arylation and Heteroarylation of Indolizines
2004 Standout
Investigating Cellular Metabolism of Synthetic Azidosugars with the Staudinger Ligation
2002 StandoutNobel
Plant Defense Against Herbivores: Chemical Aspects
2012 Standout
Plant Substances as Anti-HIV Agents Selected According to Their Putative Mechanism of Action
2004
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
1994 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Immunobiology of Dendritic Cells
2000 Standout
Microwave assisted organic synthesis—a review
2001 Standout
Homonojirimycin Isomers and N-Alkylated Homonojirimycins: Structural and Conformational Basis of Inhibition of Glycosidases
1998
Antimicrobial activity of flavonoids
2005 Standout
Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitro
1997
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Design and Fast Synthesis of C-Terminal Duplicated PotentC2-Symmetric P1/P1‘-Modified HIV-1 Protease Inhibitors
1999
Pyrrole, pyrrolidine, pyridine, piperidine and tropane alkaloids (1998 to 1999)
2000 Standout
Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application
2000
CF2H, a Hydrogen Bond Donor
2017 Standout
Primary biological aerosol particles in the atmosphere: a review
2012 Standout
"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs
1994
Action of Celgosivir (6O-Butanoyl Castanospermine) against the Pestivirus BVDV: Implications for the Treatment of Hepatitis C
2004
Works of D.L. Taylor being referenced
Cytomegalovirus and the acquired immunodeficiency syndrome
1989
Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome
2000
Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors.
1989
Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis
1988
Stilbene disulfonic acids. CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle
1991
The susceptibility of adenovirus infection to the anti-cytomegalovirus drug, ganciclovir (DHPG)
1988
In Vitro Antiretroviral Activity and In Vitro Toxicity Profile of SPD754, a New Deoxycytidine Nucleoside Reverse Transcriptase Inhibitor for Treatment of Human Immunodeficiency Virus Infection
2006
Pyrido [1,2a] Indole Derivatives Identified as Novel Nonnucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1
1999
MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection
1996
Inhibition of alpha-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus-infected T cells
1994
Basis of Relative Insensitivity of HIV-Infected JM Cells to AZT
1995
Isolation and Characterization of the Fungal Metabolite 3-O-Methylviridicatin as an Inhibitor of Tumour Necrosis Factor α-Induced Human Immunodeficiency Virus Replication
1998
Increased antiviral activity of HIV protease inhibitors of the difluorostatone type bearing (R)-valinol derivatives as novel c-termini
1994
Synergistic Inhibition of Human Immunodeficiency Virus Type 1in vitroby 6-0-butanoylcastanospermine (MDL 28574) in Combination with Inhibitors of the Virus-Encoded Reverse Transcriptase and Proteinase
1995
Naturally Occurring Pyrrolizidines: Inhibition of α-Glucosidase 1 and Anti-HIV Activity of One Stereoisomer
1992